Drug

Ethiodized Oil

44 flagged reaction(s) · 802 total co-reports · max PRR 20.5

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Metastases To Central Nervous System	16	20.5	20.7	signal
2	Product Use In Unapproved Indication	291	19.5	25.0	signal
3	Hyperthyroidism	14	15.9	16.0	signal
4	Metastases To Liver	16	14.9	15.1	signal
5	Cerebral Infarction	22	14.7	15.0	signal
6	Hypothyroidism	26	13.4	13.6	signal
7	Ascites	23	12.8	13.0	signal
8	Disseminated Intravascular Coagulation	11	12.8	12.9	signal
9	Hepatic Encephalopathy	7	12.3	12.3	signal
10	Acute Respiratory Distress Syndrome	13	12.0	12.1	signal
11	Aspartate Aminotransferase Increased	37	11.4	11.7	signal
12	Pancytopenia	36	10.6	10.9	signal
13	Hepatic Steatosis	12	10.6	10.7	signal
14	Bone Marrow Failure	13	10.4	10.5	signal
15	Drug Reaction With Eosinophilia And Systemic Symptoms	16	10.3	10.4	signal
16	Ulcer	9	9.3	9.3	signal
17	Hepatic Failure	17	9.2	9.3	signal
18	Transaminases Increased	12	8.8	8.9	signal
19	Nephropathy	5	8.7	8.8	signal
20	Acute Hepatic Failure	7	8.4	8.5	signal
21	Skin Ulcer	13	8.2	8.3	signal
22	Pulmonary Embolism	48	8.2	8.5	signal
23	Hepatitis C	6	8.0	8.1	signal
24	Hyperbilirubinaemia	5	7.9	8.0	signal
25	Pneumonitis	12	7.3	7.3	signal
26	Device Use Issue	7	6.6	6.7	signal
27	Toxic Skin Eruption	4	6.5	6.5	signal
28	Device Dislocation	17	6.4	6.5	signal
29	Hepatic Function Abnormal	14	6.2	6.2	signal
30	Nephropathy Toxic	4	5.9	5.9	signal
31	Metastases To Lung	4	5.7	5.7	signal
32	Anaphylactic Shock	8	5.1	5.1	signal
33	Thrombotic Microangiopathy	3	5.1	5.1	signal
34	Hepatocellular Injury	4	4.6	4.6	signal
35	Premature Baby	8	4.3	4.4	signal
36	Palmar-plantar Erythrodysaesthesia Syndrome	6	4.2	4.2	signal
37	Caesarean Section	3	4.2	4.2	signal
38	Premature Delivery	4	4.1	4.1	signal
39	Neoplasm Progression	7	3.3	3.3	signal
40	Bone Loss	3	3.2	3.2	no signal
41	Incorrect Route Of Drug Administration	7	3.2	3.2	signal
42	Multiple Fractures	3	3.0	3.0	no signal
43	Hepatic Cancer	4	2.7	2.7	no signal
44	Myelosuppression	5	2.4	2.4	no signal